The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 8261-8265

  Lieu, Kim G ^a   Brice, Aaron ^a   Wiltzer, Linda ^a   Hirst, Bevan ^a   Jans, David A ^a   Blondel, Danielle ^b   Moseley, Gregory W ^a  

^a MONASH UNIVERSITY   (Australia)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; STAT3 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN P;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; INHIBITION KINETICS; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RABIES; RABIES VIRUS; SIGNAL TRANSDUCTION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOKINE RECEPTOR GP130; GREEN FLUORESCENT PROTEINS; IMMUNE EVASION; INTERFERONS; LUCIFERASES; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; PHOSPHOPROTEINS; RABIES VIRUS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VIRAL STRUCTURAL PROTEINS;

EID: 84880296106     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00989-13     Document Type: Article

References (28)

1. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferonmediated signalling. Nat. Rev. Immunol. 5:375-386.
2. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
3. Versteeg GA, García-Sastre A. 2010. Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 13:508-516.
4. Ashour J, Laurent-Rolle M, Shi P-Y, García-Sastre A. 2009. NS5 of dengue virus mediates STAT2 binding and degradation. J. Virol. 83:5408-5418.
5. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. 2009. Dengue virus NS5 inhibits interferon-α signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J. Infect. Dis. 200:1261-1270.
6. Wiltzer L, Larrous F, Oksayan S, Ito N, Marsh GA, Wang LF, Blondel D, Bourhy H, Jans DA, Moseley GW. 2012. Conservation of a unique mechanism of immune evasion across the Lyssavirus genus. J. Virol. 86: 10194-10199.
7. Parisien J-P, Lau JF, Rodriguez JJ, Ulane CM, Horvath CM. 2002. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J. Virol. 76:4190-4198.
8. Precious B, Young DF, Andrejeva L, Goodbourn S, Randall RE. 2005. In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J. Gen. Virol. 86:151-158.
9. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:297-314.
10. Garbers C, Hermanns HM, Schaper F, Müller-Newen G, Grötzinger J, Rose-John S, Scheller J. 2012. Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev. 23:85-97.
11. Levy DE, Lee C-K. 2002. What does Stat3 do? J. Clin. Invest. 109:1143-1148.
12. Palosaari H, Parisien J-P, Rodriguez JJ, Ulane CM, Horvath CM. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77:7635-7644.
13. Ulane CM, Rodriguez JJ, Parisien J-P, Horvath CM. 2003. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J. Virol. 77:6385-6393.
14. Caignard G, Lucas-Hourani M, Dhondt KP, Labernardiére J-L, Petit T, Jacob Y, Horvat B, Tangy F, Vidalain P-O. 2013. The V protein of Tioman virus is incapable of blocking type I interferon signaling in human cells. PLoS One 8:e53881. doi:10.1371/journal.pone.0053881.
15. Rodriguez JJ, Parisien J-P, Horvath CM. 2002. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76:11476-11483.
16. Rodriguez JJ, Wang L-F, Horvath CM. 2003. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J. Virol. 77:11842-11845.
17. Brzózka K, Finke S, Conzelmann K-K. 2006. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J. Virol. 80:2675-2683.
18. Vidy A, El Bougrini J, Chelbi-Alix MK, Blondel D. 2007. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J. Virol. 81:4255-4263.
19. Vidy A, Chelbi-Alix M, Blondel D. 2005. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 79:14411-14420.
20. Chelbi-Alix M, Vidy A, El Bougrini J, Blondel D. 2006. Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies. J. Interferon Cytokine Res. 26:271-280.
21. Ito N, Moseley GW, Blondel D, Shimizu K, Rowe CL, Ito Y, Masatani T, Nakagawa K, Jans DA, Sugiyama M. 2010. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J. Virol. 84:6699-6710.
22. Oksayan S, Ito N, Moseley GW, Blondel D. 2012. Subcellular trafficking in rhabdovirus infection and immune evasion: a novel target for therapeutics. Infect. Disord. Drug Targets 12:38-58.
23. Jackson AC. 2003. Rabies virus infection: an update. J. Neurovirol. 9:253-258.
24. Watanabe K, Saito K, Kinjo M, Matsuda T, Tamura M, Kon S, Miyazaki T, Uede T. 2004. Molecular dynamics of STAT3 on IL-6 signaling pathway in living cells. Biochem. Biophys. Res. Commun. 324:1264-1273.
25. Moseley GW, Lahaye X, Roth DM, Oksayan S, Filmer RP, Rowe CL, Blondel D, Jans DA. 2009. Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J. Cell Sci. 122:3652-3662.
26. Oksayan S, Wiltzer L, Rowe CL, Blondel D, Jans DA, Moseley GW. 2012. A novel nuclear trafficking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein. J. Biol. Chem. 287:28112-28121.
27. Pasdeloup D, Poisson N, Raux H, Gaudin Y, Ruigrok RWH, Blondel D. 2005. Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology 334:284-293.
28. Puri M, Lemon K, Duprex WP, Rima BK, Horvath CM. 2009. A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J. Virol. 83:6347-6356.